House Judiciary Committee Advances Four Drug Pricing Bills, Although Changes Are Still Likely

US committee will likely re-examine the language regarding the burden of proof in a bill prohibiting pay-for-delay settlements.

Capitol Building, Washington DC
The House Judiciary Committee advanced four drug pricing bills to the full chamber.

More from Pricing Debate

More from Market Access